CD7 expression and its prognostic significance in acute myeloid leukemia patients with wild-type or mutant CEBPA

被引：0
|
作者：
朱名俣 [1 ]
机构：
[1] Dept Hematol,1st Affil Hosp,Zhejiang Univ
来源：
China Medical Abstracts(Internal Medicine) | 2020年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R733.71 [急性白血病];
学科分类号：
摘要：
Objective To analyze the prognostic value of CD7expression in newly diagnosed acute myeloid leukemia（AML） patients,and to further explore the correlation between CD7 expression and CEBPA mutation,and to clarify the prognostic value of CD7;in AML patients with wild-type （WT） or mutant-type （MT） CEBPA.Methods The clinical data of 298 newly diagnosed non-
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia
    Sally L Rogers
    Yun Zhao
    Xiaoyan Jiang
    Connie J Eaves
    Dixie L Mager
    Arefeh Rouhi
    Molecular Cancer, 9
  • [22] EPIGENETIC MODIFICATIONS CORRELATE WITH EXPRESSION OF THE LEUKEMIC PROGNOSTIC MARKER CD7 IN CHRONIC MYELOID LEUKEMIA
    Rouhi, A.
    Rogers, S. L.
    Zhao, Y.
    Eaves, C. J.
    Mager, D. L.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S14 - S15
  • [23] Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression
    Jen, Wei-Ying
    Sasaki, Koji
    Loghavi, Sanam
    Wang, Sa A.
    Qiao, Wei
    Borthakur, Gautam
    Ravandi, Farhad
    Kadia, Tapan M.
    Issa, Ghayas C.
    Short, Nicholas J.
    Yilmaz, Musa
    Daver, Naval G.
    Dinardo, Courtney D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (06) : 2259 - 2263
  • [24] The Frequency of Aberrant CD7 Antigen Expression in Acute Myeloid Leukaemia Patients
    Raza, Hassan
    Fatima, Mavra
    Noor, Tayyab
    Umer, Shereen
    Imran, Ayisha
    Malik, Nauman A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [25] Prognostic significance of CD56 antigen expression in acute myeloid leukemia
    Di Bona, E
    Sartori, R
    Zambello, R
    Guercini, N
    Madeo, D
    Rodeghiero, F
    HAEMATOLOGICA, 2002, 87 (03) : 250 - 256
  • [26] CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia
    Gomes-Silva, Diogo
    Atilla, Erden
    Atilla, Pinar Ataca
    Mo, Feiyan
    Tashiro, Haruko
    Srinivasan, Madhuwanti
    Lulla, Premal
    Rouce, Rayne H.
    Cabral, Joaquim M. S.
    Ramos, Carlos A.
    Brenner, Malcolm K.
    Mamonkin, Maksim
    MOLECULAR THERAPY, 2019, 27 (01) : 272 - 280
  • [27] Expression of Tdt and/or CD7 defines a subset of acute myeloid leukemia with poor prognosis.
    Venditti, A
    DelPoeta, G
    Buccisano, F
    Tamburini, A
    Cox, MC
    Forte, L
    Aronica, G
    Bruno, A
    Santinelli, S
    DelMoro, B
    Epiceno, AM
    Amadori, S
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 483 - 483
  • [28] Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
    Xu, Xiaoyu
    Cai, Wenzhi
    Cai, Ping
    Zhang, Ling
    Yao, Hong
    Zhang, Tongtong
    Shen, Hongjie
    Chen, Suning
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] KEVETRIN TARGETS TP53 WILD-TYPE AND MUTANT ACUTE MYELOID LEUKEMIA CELLS
    Napolitano, R.
    De Matteis, S.
    Carloni, S.
    Ghetti, M.
    Liverani, C.
    Bochicchio, M. T.
    di Rora, A. Ghelli Luserna
    Fontana, M. C.
    Padella, A.
    Mercatali, L.
    Menon, K.
    Musuraca, G.
    Martinelli, G.
    Simonetti, G.
    HAEMATOLOGICA, 2020, 105 : S88 - S89
  • [30] The prognostic significance of CD25 & CD123 expression in acute myeloid leukemia
    Thasneem, F. T.
    Narayanan, G.
    Nair, S. G.
    Purushothaman, P. N.
    Thambi, S. M.
    Jayasudha, A. V.
    Km, J. Krishna
    ANNALS OF ONCOLOGY, 2024, 35
12345